4H045 ペプチド又は蛋白質技術 Patent Trends
The Theme Code "ペプチド又は蛋白質技術" had 2,048 patent application filings in the publication-lag-adjusted comparison period (2024-01-01 to 2024-10-31). This is a significantly decreased of -606 filings (-22.8%) over 2,654 they had in the same period of the previous year (2023-01-01 to 2023-10-31).
The highest number of filings in 2021 with 4,523 cases, and their lowest number in 2024 with 2,116 cases (years covered: 2021, 2022, 2023, 2024).
The mean of the number of filings over the last 4 years (2021 to 2024, 13,672 cases in total) is 3,418, and the median is 3,516. The coefficient of variation (standard deviation/mean) is 0.26, and filings have been large fluctuations.
| Index | Value |
|---|---|
| Average | 3,418 patents |
| Std Dev | 875 |
| COV | 0.26 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 151 cases | -92.9% |
| 2024 year | 2,116 cases | -35.2% |
| 2023 year | 3,267 cases | -13.25% |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for ペプチド又は蛋白質技術[4H045] for the period of the last 6 years (2020 to 2025). You can compare the information in this report with the trends in your competitors’ patent filings and technologies.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of ペプチド又は蛋白質技術, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, and their top coapplicants (joint research partners, alliance partners). It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
ペプチド又は蛋白質技術, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of ペプチド又は蛋白質技術 over the last 6 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
ペプチド又は蛋白質技術 JP patent filing trend (unit: cases)
| Year | Cases |
|---|---|
| 2021 | 4,523 |
| 2022 | 3,766 |
| 2023 | 3,267 |
| 2024 | 2,116 |
| 2025 | 151 |
Patent Landscape
Patent landscaping is a visualization of the distribution of patent filings (application focus areas) for each technical keyword. Mountains and islands indicated by heatmap contours represent clusters of patent applications filed, and red areas on the heatmap indicate many patent filings relating to the keyword.
The patent landscape for ペプチド又は蛋白質技術 gives an intuitive understanding of what patent filings they have made and what technical position is to be established. By selecting filing year checkboxes and filtering, you can track their past filing trends (what technical area they have focused on).
By selecting applicant/patent holder checkboxes and filtering, you can visually grasp the technical areas of the filings for each applicant and the partnerships or alliances formed. Please use it as a guide for patent analysis and IP landscaping.
Keywords (importance)
Top keywords frequently used in patent filings for ペプチド又は蛋白質技術 are shown below.
Top keywords for ペプチド又は蛋白質技術
| Keyword | Score |
|---|---|
| 結合 | 100.0 |
| 抗体 | 98.27 |
| 組成 | 95.35 |
| 細胞 | 80.61 |
| 疾患 | 60.05 |
| 活性 | 56.39 |
| 配列 | 54.73 |
| 治療 | 51.67 |
| タンパク質 | 45.23 |
| 特異 | 41.87 |
| 修正 | 41.14 |
| 癌 | 36.78 |
| ヒト | 34.14 |
| 予防 | 31.41 |
| 発現 | 30.43 |
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 13,823 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
ペプチド又は蛋白質技術[4H045]
Recent publications
| Publication No. | Title | Bibliographic info | Theme |
|---|---|---|---|
| 1. JPP7919671 | 脂肪酸トランスポーターの細胞内動態の分析方法、及び脂肪酸トランスポーター改変タンパク質の利用 | ・Applicant 公立大学法人大阪 ・Filing date 2021-02-25 ・Publication date 2026-09-14 | 2G045, 4B063, 4B065, 4H045 |
| 2. JPP7920139 | タンパク質を濃縮するための方法 | ・Applicant ブリストル-マイヤーズスクイブカンパニー ・Filing date 2021-10-04 ・Publication date 2026-09-14 | 4B029, 4C076, 4C084, 4C085, 4H045 |
| 3. JPP7920340 | 低減された非標的脱アミノ化を有する核酸塩基エディターおよび核酸塩基エディターの特徴づけのためのアッセイ | ・Applicant ビームセラピューティクスインク ・Filing date 2020-01-31 ・Publication date 2026-09-14 | 4H045 |
| 4. JPP7919739 | アストロサイトを培養する方法 | ・Applicant 合同会社STADION ・Filing date 2022-07-29 ・Publication date 2026-09-14 | 4B065, 4C087, 4H045 |
| 5. JPP7920169 | 抗ＧＰＲＣ５ＤｘＢＣＭＡｘＣＤ３三重特異性抗体およびその使用 | ・Applicant イノベントバイオロジクス(スーチョウ)カンパニーリミティド ・Filing date 2022-02-18 ・Publication date 2026-09-14 | 4B065, 4C076, 4C085, 4C087, 4H045 |
| 6. JPA-HYO2026-531090 | ヒトＴ細胞受容体のβ鎖の断片ＴＲＢＶ５－１に結合する単鎖可変領域フラグメント及びそれに由来する分子 | ・Applicant ティベルバイオテックエスアールエル, ピターロミケーレ ・Filing date 2023-09-05 ・Publication date 2026-09-14 | 4C076, 4H045 |
| 7. JPP7919800 | 多重特異性キメラ抗原受容体及びその使用 | ・Applicant レジェンドバイオテックアイルランドリミテッド ・Filing date 2021-07-16 ・Publication date 2026-09-14 | 4B065, 4C084, 4C087, 4H045 |
| 8. JPP7919727 | 呼吸器合胞体ウイルスを中和する全ヒト抗体の設計および使用 | ・Applicant センターフォーエクセレンスインモレキュラーセルサイエンスチャイニーズアカデミーオブサイエンシーズ ・Filing date 2022-10-08 ・Publication date 2026-09-14 | 4B064, 4B065, 4C076, 4C084, 4C085, +2 more |
| 9. JPP7920144 | 肺がんのためのＬＡＧ－３アンタゴニスト療法 | ・Applicant ブリストル-マイヤーズスクイブカンパニー ・Filing date 2021-10-22 ・Publication date 2026-09-14 | 4C084, 4C085, 4C086, 4C206, 4H045 |
| 10. JPA-HYO2026-530953 | ＤＥＣＴＩＮ－１及びＴＲＯＰ－２に結合する多重特異性結合タンパク質ならびにその使用方法 | ・Applicant ドレンバイオマネジメントインコーポレイテッド ・Filing date 2024-07-30 ・Publication date 2026-09-11 | 4B064, 4B065, 4H045 |
| 11. JPA-HYO2026-530959 | ヒト化ＭＵＣ１抗体および抗体薬物コンジュゲート | ・Applicant サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッド ・Filing date 2024-07-31 ・Publication date 2026-09-11 | 2G043, 4B063, 4B065, 4C076, 4H045 |
| 12. JPA-HYO2026-530929 | 表面修飾ウィルスカプシドの調製方法 | ・Applicant ボレアセラピューティクスエスアールエル ・Filing date 2024-07-22 ・Publication date 2026-09-11 | 4C076, 4H045 |
| 13. JPA-HYO2026-530995 | 抗ＭＵＣ１６抗体およびその使用 | ・Applicant ウーシーバイオロジクスアイルランドリミテッド ・Filing date 2024-08-09 ・Publication date 2026-09-11 | 4B064, 4B065, 4H045 |
| 14. JPA-HYO2026-531044 | 分子糊分解誘導剤に基づく抗体－薬物コンジュゲート及びその使用 | ・Applicant アンスティチュート、ナシオナル、ドゥ、ラ、サンテ、エ、ドゥ、ラ、ルシェルシュ、メディカル, アンスティチュー・ナショナル・デ・シアンス・アプリケース・ドゥ・リヨン, エコールシュプシミフィズエレクトロニクリヨン(セーペーウーリヨン), セントレナシオナルデラルシェルシェシエンティフィーク, セントレレオン-ベラード, ホスピス・シビル・ドゥ・リヨン, マブリンクビオシオンス, ユニベルシテクロードベルナールリヨンプルミエ ・Filing date 2024-08-23 ・Publication date 2026-09-11 | 4C076, 4H045 |
| 15. JPA-HYO2026-530999 | 立体閉塞部分を含むＣｙＣＡＴハーフボディ分子 | ・Applicant モルフォシス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ・Filing date 2024-08-13 ・Publication date 2026-09-11 | 4H045 |
Same industry / competition company information (JP)
{'ja': '技術テーマ「ペプチド又は蛋白質技術」における上位出願人の特許情報を以下に示します。各企業の特許件数を比較することで、過去および現在の各社の技術テーマにおける研究開発状況や、技術テーマにおける各社の位置付けを確認できます。なお、特許は出願から公開までに一年半のタイムラグがあるため、一年半より直近の状況については分析できない点に注意する必要があります。', 'en': "The patent information of the higher applicant in the technical theme ペプチド又は蛋白質技術 is shown below. By comparing the number of patents of each company, you can check the research and development status of each company's past and present technical themes and the position of each company in the technical theme. Patents have a time lag of about 18 months from filing to publication."}
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Comparing the number of applications of each company, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 101 cases, followed by イーライリリーアンドカンパニー with 60 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 101 cases |
| イーライリリーアンドカンパニー | 60 cases |
| ジェネンテックインコーポレイテッド | 51 cases |
| エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | 46 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 32 cases |
| ヤンセンバイオテツクインコーポレーテツド | 31 cases |
Trends in filing of joint patent applications for the target period (2020 to 2025).
Comparing the number of applications of each company, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last for the target period (2020 to 2025) with 362 cases, followed by ジェネンテックインコーポレイテッド with 211 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 362 cases |
| ジェネンテックインコーポレイテッド | 211 cases |
| ヤンセンバイオテツクインコーポレーテツド | 200 cases |
| イーライリリーアンドカンパニー | 168 cases |
| エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | 151 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 140 cases |
Same industry / competition company JP patent filing ranking
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
競合企業の長期推移をどう読むか
同業や競合企業の長期的な特許出願件数の推移から、長期トレンドと出願件数の山や谷を確認することができます。
解説の続きを読む
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 6 companies in the same industry over the past 6 years.
Competitor filing ranking
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 362 |
| ジェネンテックインコーポレイテッド | 211 |
| ヤンセンバイオテツクインコーポレーテツド | 200 |
| イーライリリーアンドカンパニー | 168 |
| エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | 151 |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 140 |
Top company information (JP)
{'ja': '技術テーマ「ペプチド又は蛋白質技術」における上位出願人の特許情報を以下に示します。各企業の特許件数を比較することで、過去および現在の各社の技術テーマにおける研究開発状況や、技術テーマにおける各社の位置付けを確認できます。なお、特許は出願から公開までに一年半のタイムラグがあるため、一年半より直近の状況については分析できない点に注意する必要があります。', 'en': "The patent information of the higher applicant in the technical theme ペプチド又は蛋白質技術 is shown below. By comparing the number of patents of each company, you can check the research and development status of each company's past and present technical themes and the position of each company in the technical theme. Patents have a time lag of about 18 months from filing to publication."}
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
競合企業との比較のポイント
同業や競合企業が特許に注力している分野を知ることで、自社の戦略や製品開発の方向性を把握することができます。
解説の続きを読む
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
among the top coapplicants, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 101 cases, followed by イーライリリーアンドカンパニー with 60 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 101 cases |
| イーライリリーアンドカンパニー | 60 cases |
| ジェネンテックインコーポレイテッド | 51 cases |
Trends in filing of joint patent applications for the target period (2020 to 2025).
among the top coapplicants, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last for the target period (2020 to 2025) with 362 cases, followed by ジェネンテックインコーポレイテッド with 211 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 362 cases |
| ジェネンテックインコーポレイテッド | 211 cases |
| イーライリリーアンドカンパニー | 168 cases |
Top company JP patent filing ranking
Below is a ranking of the number of JP patent applications by ペプチド又は蛋白質技術’s top 3 coapplicants over the last 6 years.
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
競合企業の長期推移をどう読むか
同業や競合企業の長期的な特許出願件数の推移から、長期トレンドと出願件数の山や谷を確認することができます。
解説の続きを読む
Top co-applicant filing ranking
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 362 |
| ジェネンテックインコーポレイテッド | 211 |
| ヤンセンバイオテツクインコーポレーテツド | 200 |
Top company, Change in the Number of JP Patents
Below is a patent map showing the changes in the numbers of JP patent filings by ペプチド又は蛋白質技術’s top 3 coapplicants over the last 6 years.
Top co-applicant filing ranking
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 362 |
| ジェネンテックインコーポレイテッド | 211 |
| ヤンセンバイオテツクインコーポレーテツド | 200 |
Top company details
Trends in filing of joint patent applications with リジェネロン・ファーマシューティカルズ・インコーポレイテッド
ペプチド又は蛋白質技術 filed 362 joint applications with リジェネロン・ファーマシューティカルズ・インコーポレイテッド for the analysis period (2020 to 2025).
The mean of the number of filings over the last 5 years (2020 to 2024, 362 cases in total) is 72.4, and the median is 63.0. The coefficient of variation (standard deviation/mean) is 0.5, and filings have been large fluctuations.
Because some years show zero filings in the collected data, strong trend claims are avoided; see the yearly table. The highest number of filings in 2020 with 141 cases, and their lowest number in 2024 with 38 cases (years covered: 2020, 2021, 2022, 2023, 2024).
| Index | Value |
|---|---|
| Average | 72.4 patents |
| Std Dev | 35.6 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 0 cases | -100% |
| 2024 year | 38 cases | -39.7% |
| 2023 year | 63 cases | +14.55% |
Trends in filing of joint patent applications with イーライリリーアンドカンパニー
ペプチド又は蛋白質技術 filed 168 joint applications with イーライリリーアンドカンパニー for the analysis period (2020 to 2025).
The mean of the number of filings over the last 5 years (2020 to 2024, 160 cases in total) is 32.0, and the median is 33.0. The coefficient of variation (standard deviation/mean) is 0.20, and filings have been moderate fluctuations.
The highest number of filings in 2022 with 38 cases, and their lowest number in 2024 with 20 cases (years covered: 2020, 2021, 2022, 2023, 2024).
| Index | Value |
|---|---|
| Average | 32.0 patents |
| Std Dev | 6.4 |
| COV | 0.20 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 8 cases | -60.0% |
| 2024 year | 20 cases | -37.5% |
| 2023 year | 32 cases | -15.79% |
Trends in filing of joint patent applications with ジェネンテックインコーポレイテッド
ペプチド又は蛋白質技術 filed 211 joint applications with ジェネンテックインコーポレイテッド for the analysis period (2020 to 2025).
The mean of the number of filings over the last 5 years (2020 to 2024, 208 cases in total) is 41.6, and the median is 45.0. The coefficient of variation (standard deviation/mean) is 0.4, and filings have been large fluctuations.
The highest number of filings in 2021 with 65 cases, and their lowest number in 2024 with 17 cases (years covered: 2020, 2021, 2022, 2023, 2024).
| Index | Value |
|---|---|
| Average | 41.6 patents |
| Std Dev | 16.4 |
| COV | 0.4 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 3 cases | -82.4% |
| 2024 year | 17 cases | -45.2% |
| 2023 year | 31 cases | -31.1% |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
競合企業との比較のポイント
同業や競合企業が特許に注力している分野を知ることで、自社の戦略や製品開発の方向性を把握することができます。
解説の続きを読む